Rezolute
RZLT
Rezolute (RZLT) news
Recent news
Rezolute: topline results expected in 2H26
AInvest Wire · Jun 2, 2026Rezolute - topline results for uplift study expected in second half of 2026
AInvest Wire · Jun 2, 2026US FDA lifts partial clinical hold on Rezolute's blood sugar treatment
US FDA lifts partial clinical hold on Rezolute's blood sugar treatment The US Food and Drug Administration (FDA) recently announced the removal of partial clinical holds on RZ358 (ersodetug), a potential treatment for hypoglycemia caused by congenital hyperinsulinism (HI) [1]. RZ358, a fully human…
AInvest Wire · Sep 9, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.